Percutaneous Respiratory Assist Catheter
经皮呼吸辅助导管
基本信息
- 批准号:7824812
- 负责人:
- 金额:$ 1.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAcute respiratory failureAdjuvantAdult Respiratory Distress SyndromeAffectAmericanAnimalsBicarbonate IonBicarbonate IonsBloodBlood PlateletsBlood flowBreathingCaliberCarbon DioxideCardiovascular systemCathetersChronicChronic Obstructive Airway DiseaseChronic lung diseaseClinicalDataDevelopmentDevicesEarly treatmentEnzymesEthylene GlycolsEvaluation StudiesExcisionFailureFiberFundingGasesGlutaralGoalsGrantHealedHealthHealthcareHeartHemolysisHospitalizationHourHypercapniaImageryImmobilized EnzymesImplantIn SituIntensive Care UnitsLeadLinkLiquid substanceLungMechanical ventilationMembraneMethodsModelingMotionOxygenPatientsPatternPeripheralPhysiologicalPlatelet ActivationPneumoniaPolymersProteolysisPublishingPulmonary EmphysemaResearchRestSimulateSiteSocietiesStructureStudy modelsSurfaceTechniquesTranslatingVeinsVenous systemabstractingaging populationbasebiomaterial compatibilityblood oxygenatorcarbonate dehydratasedesignethylene glycolhealinghemodynamicsimprovedlung injurynovelprototyperespiratoryrespiratory assistresponsesuccesstherapy durationtool
项目摘要
Abstract
Each year several hundred thousand Americans suffer short term lung failure requiring respiratory
support within the intensive care unit. The objective of this proposal is to develop a percutaneous
respiratory assist catheter (PRAC) that can be inserted into the venous system to provide
supplemental breathing support, independent of the lungs, for patients requiring short-term (~ 4-7
day) respiratory assistance. The PRAC will be designed for percutaneous insertion into a peripheral
vein and placement in the central venous system, where it will be exposed to all the blood returning to
the heart. The PRAC will use a rotating impeller within the fiber bundle to generate active mixing of
blood to enhance gas exchange. We will also develop novel hollow fiber membranes that incorporate
immobilized enzymes that will further accelerate CO2 removal. The specific aims of the project are to:
1. Design and evaluate new mixing impeller structures that increase CO2 removal by increasing fluid
motion into and within the hollow fiber bundle. The designs will be developed using computational
fluid dynamics (CFD).
2. Develop an enzymatic coating of carbonic anhydrase to accelerate CO2 removal and improve the
biocompatibility of hollow fiber membranes.
3. Perform acute (6 hour) and chronic (7 day) calf implants of the PRAC to assess gas exchange,
cardiovascular impact, and biocompatibility.
Our target is a percutaneous assist catheter (20-25 Fr or smaller) that can provide 90-120 ml/min of
CO2 removal when used as an adjuvant or replacement to existing therapy for patients with acute lung
failure (ARDS, pneumonia) or acute on chronic lung failure (COPD with exacerbation). Project Narrative
Several hundred thousand Americans each year suffer from short-term lung failure that requires
hospitalization so that breathing support for the patient can be provided. The current methods for
providing breathing support to these patients have problems and complications associated with them.
The proposed project will develop a simple catheter that can be inserted into a patient's vein to
provide breathing support while allowing the lungs to rest and heal.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William J. Federspiel其他文献
William J. Federspiel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William J. Federspiel', 18)}}的其他基金
Hemoadsorption Device for Selective Removal of Cell-Free Plasma Hemoglobin During Extracorporeal Therapies.
用于在体外治疗期间选择性去除无细胞血浆血红蛋白的血液吸附装置。
- 批准号:
10527451 - 财政年份:2022
- 资助金额:
$ 1.85万 - 项目类别:
Design of Extracorporeal Specific Antibody Filters
体外特异性抗体过滤器的设计
- 批准号:
6730430 - 财政年份:2003
- 资助金额:
$ 1.85万 - 项目类别:
Design of Extracorporeal Specific Antibody Filters
体外特异性抗体过滤器的设计
- 批准号:
7115909 - 财政年份:2003
- 资助金额:
$ 1.85万 - 项目类别:
Design of Extracorporeal Specific Antibody Filters
体外特异性抗体过滤器的设计
- 批准号:
6803991 - 财政年份:2003
- 资助金额:
$ 1.85万 - 项目类别:
Design of Extracorporeal Specific Antibody Filters
体外特异性抗体过滤器的设计
- 批准号:
6943068 - 财政年份:2003
- 资助金额:
$ 1.85万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 1.85万 - 项目类别:














{{item.name}}会员




